SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-006772
Filing Date
2020-02-26
Accepted
2020-02-26 16:04:21
Documents
14
Period of Report
2020-02-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arna-8k_20200226.htm   iXBRL 8-K 40756
2 EX-99.1 arna-ex991_6.htm EX-99.1 276944
3 GRAPHIC g1v10ogvi4h0000001.jpg GRAPHIC 2287
  Complete submission text file 0001564590-20-006772.txt   464124

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA arna-20200226.xsd EX-101.SCH 5976
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE arna-20200226_lab.xml EX-101.LAB 18706
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arna-20200226_pre.xml EX-101.PRE 11179
9 EXTRACTED XBRL INSTANCE DOCUMENT arna-8k_20200226_htm.xml XML 3430
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31161 | Film No.: 20655627
SIC: 2834 Pharmaceutical Preparations